More

    Morgan Stanley cuts Lululemon stock target, keeps Overweight rating By Investing.com



    Morgan Stanley has maintained its Overweight rating on Lululemon Athletica Inc. (NASDAQ: NASDAQ:) but reduced the price target to $329 from the previous $404 as the firm anticipates a potential second-quarter earnings per share (EPS) beat and an increase in full-year guidance driven by factors that may not address broader debates surrounding the company.

    The analyst from Morgan Stanley noted that while the upcoming financial results might not settle larger discussions about Lululemon, the company’s prospects for the second half of the year appear promising.

    The optimism is based on Lululemon’s proven historical performance and its strong market position, which the analyst believes may counter the current pessimistic market sentiment and the low expectations set for the company’s yearly earnings.

    Despite the lowered price target, the analyst underscored Lululemon’s attractive risk/reward balance, given its depressed valuation and the potential for positive change in the latter half of the year. The firm’s stance remains that the stock is likely to perform well moving forward.

    The adjustment in Lululemon’s price target reflects a cautious yet optimistic view of the company’s near-term growth potential and its ability to outperform despite the challenges. Morgan Stanley’s analysis suggests that while immediate concerns might persist, the long-term outlook for Lululemon remains positive.

    In other recent news, Stifel revised its price target for Lululemon shares to $370, citing a cautious stance on the company’s near-term prospects. The firm’s revised revenue estimate stands at approximately $2.362 billion with earnings per share (EPS) at $2.88, both figures falling below the company’s guidance.

    Simultaneously, BTIG reaffirmed its Buy rating and $360.00 price target on Lululemon shares, highlighting the company’s growth potential despite recent challenges. These challenges include a slowdown in the second quarter and concerns over product design and innovation, particularly the temporary halt in sales of Breezethrough leggings.

    Moreover, Goldman Sachs downgraded Lululemon’s stock from Buy to Neutral, reducing its price target to $286.00 due to issues with product execution and innovation. The firm cited recent execution challenges and lackluster innovation launches as reasons for the downgrade.

    Truist Securities also revised its price target for Lululemon, lowering it to $310 but maintaining its Buy rating. This adjustment comes in response to Lululemon’s decision to halt sales of its Breezethrough collection following customer feedback.

    InvestingPro Insights

    As Morgan Stanley maintains a positive stance on Lululemon Athletica Inc. (NASDAQ:LULU), with a revised price target indicating optimism for the company’s future performance, it’s worthwhile to consider additional insights provided by InvestingPro. Lululemon’s fundamentals reflect a company with a strong financial position, as evidenced by a market cap of $33.57 billion and a robust gross profit margin of 58.34% over the last twelve months as of Q1 2023. Additionally, the company’s revenue growth stands at a healthy 15.65% for the same period, showcasing its ability to expand effectively.

    InvestingPro Tips highlight that Lululemon holds more cash than debt on its balance sheet, suggesting a solid liquidity position that could support future growth or weather economic downturns. Moreover, the company is trading at a low P/E ratio relative to near-term earnings growth, potentially indicating an undervalued stock that could offer an attractive entry point for investors. These aspects, combined with the fact that Lululemon is profitable over the last twelve months and analysts predict it will remain profitable this year, reinforce the positive outlook shared by Morgan Stanley.

    For investors seeking a more comprehensive analysis, there are additional InvestingPro Tips available, which delve into the nuances of Lululemon’s financial health and market position. These insights could further inform investment decisions and provide a deeper understanding of the company’s potential.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.


    https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png



    Source link
    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    spot_imgspot_img